Chart, Financials, Historical Prices, Industry, Messages, Options, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 47)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
30-Nov-09Freedonia Group Inc, TheThe Freedonia GroupFreedonia Focus on Cancer Therapies23$500  View Abstract
21-Nov-09Reuters Investment ProfileN/AArcturus Ventures Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: ASTRAZENECA PLC -- AZN1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ABT , AZN , GSK , MRK , NVS , PFE , RHHBY -- DRUGS3$4  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Trends, Statistics & Analysis 2010 (Summary)98$199  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettNanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary)34$199  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettNanotechnology & MEMS Industry Market Research and Competitive Analysis 2009447$299  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
Next 20
Brokerage Reports (Showing 1 to 3 of 3)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
11-Nov-09Thomson StreetEventsN/AAZN - Event Transcript of AstraZeneca PLC conference call, Nov. 10, 2009 / 11:30am ET15$75  View Abstract
30-Oct-09Thomson StreetEventsN/AAZN - Event Brief of AstraZeneca PLC conference call, Oct. 29, 2009 / 1:00pm ET21$75  View Abstract
30-Oct-09Thomson StreetEventsN/AAZN - Event Transcript of AstraZeneca PLC conference call, Oct. 29, 2009 / 1:00pm ET20$75  View Abstract
Independent Reports (Showing 1 to 10 of 44)
Release
Date [down]		 Contributor Author Title Pages Price More Info
30-Nov-09Freedonia Group Inc, TheThe Freedonia GroupFreedonia Focus on Cancer Therapies23$500View Abstract
21-Nov-09Reuters Investment ProfileN/AArcturus Ventures Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: ASTRAZENECA PLC -- AZN1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ABT , AZN , GSK , MRK , NVS , PFE , RHHBY -- DRUGS3$4View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Trends, Statistics & Analysis 2010 (Summary)98$199View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettNanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary)34$199View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettNanotechnology & MEMS Industry Market Research and Competitive Analysis 2009447$299View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.